Boyce HJ - Search Results

1

Physical Barrier Type Abuse-Deterrent Formulations: Mechanistic Understanding of Sintering-Induced Microstructural Changes in Polyethylene Oxide Placebo Tablets.

Boyce HJ, Dave VS, Scoggins M, Gurvich VJ, Smith DT, Byrn SR, Hoag SW. Boyce HJ, et al. AAPS PharmSciTech. 2020 Jan 29;21(3):86. doi: 10.1208/s12249-019-1594-6. AAPS PharmSciTech. 2020. PMID: 31997096

2

Correlation of Structural and Macroscopic Properties of Starches with Their Tabletability Using the SM(2) Approach.

Dave VS, Chanda M, Sayles M, Popielarczyk M, Boyce H, Bompelliwar SK, Bates S, Morris KR, Haware RV. Dave VS, et al. J Pharm Sci. 2015 Nov;104(11):3870-3882. doi: 10.1002/jps.24601. Epub 2015 Jul 30. J Pharm Sci. 2015. PMID: 26235472

3

Development and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral Candidiasis.

Kong EF, Tsui C, Boyce H, Ibrahim A, Hoag SW, Karlsson AJ, Meiller TF, Jabra-Rizk MA. Kong EF, et al. Antimicrob Agents Chemother. 2015 Nov 23;60(2):881-9. doi: 10.1128/AAC.02624-15. Print 2016 Feb. Antimicrob Agents Chemother. 2015. PMID: 26596951 Free PMC article.

4

Lubricant-Sensitivity Assessment of SPRESS^® B820 by Near-Infrared Spectroscopy: A Comparison of Multivariate Methods.

Dave VS, Popielarczyk M, Boyce H, Al-Achi A, Ike-Amaechi E, Hoag SW, Haware RV. Dave VS, et al. J Pharm Sci. 2017 Feb;106(2):537-545. doi: 10.1016/j.xphs.2016.09.018. Epub 2016 Nov 7. J Pharm Sci. 2017. PMID: 27832838

5

In Vitro Assessment of Nasal Insufflation of Comminuted Drug Products Designed as Abuse Deterrent Using the Vertical Diffusion Cell.

Boyce H, Smith D, Byrn S, Saluja B, Qu W, Gurvich VJ, Hoag SW. Boyce H, et al. AAPS PharmSciTech. 2018 May;19(4):1744-1757. doi: 10.1208/s12249-017-0947-2. Epub 2018 Mar 26. AAPS PharmSciTech. 2018. PMID: 29582347

6

Physical barrier type abuse-deterrent formulations: monitoring sintering-induced microstructural changes in polyethylene oxide placebo tablets by near infrared spectroscopy (NIRS).

Boyce HJ, Ibrahim A, Hoag SW. Boyce HJ, et al. Drug Dev Ind Pharm. 2018 Nov;44(11):1885-1894. doi: 10.1080/03639045.2018.1504965. Epub 2018 Sep 5. Drug Dev Ind Pharm. 2018. PMID: 30070152

7

Assessing Drug Release from Manipulated Abuse Deterrent Formulations.

Feng X, Zidan A, Kamal NS, Xu X, Sun D, Walenga R, Boyce H, Cruz CN, Ashraf M. Feng X, et al. AAPS PharmSciTech. 2020 Jan 2;21(2):40. doi: 10.1208/s12249-019-1595-5. AAPS PharmSciTech. 2020. PMID: 31897805

8

Preferential Oxycodone Loss of Physically Manipulated Abuse Deterrent Oxycodone HCl Extended Release Tablets Prepared for Nasal Insufflation Studies.

Meng Z, Boyce HJ, Sun D, Kinjo M, Raofi S, Li T. Meng Z, et al. Among authors: boyce hj. Pharm Res. 2021 Jul;38(7):1263-1278. doi: 10.1007/s11095-021-03066-0. Epub 2021 Jun 14. Pharm Res. 2021. PMID: 34128146

9

A Chewing Study of Abuse-Deterrent Tablets Containing Polyethylene Oxide Using a Robotic Simulator.

Chen B, Zhang F, Dhupia J, Morgenstern MP, Costello M, Boyce H, Sun WJ, Raofi S, Tian L, Xu W. Chen B, et al. AAPS PharmSciTech. 2023 Nov 29;24(8):245. doi: 10.1208/s12249-023-02706-5. AAPS PharmSciTech. 2023. PMID: 38030835

10

Particle size affects pharmacokinetics of milled oxycodone hydrochloride tablet products following nasal insufflation in nondependent, recreational opioid users.

Raofi S, Kinjo M, Sun D, Li Z, Boyce H, Natarajan K, Frost M, Zhao L, Luke M, Lionberger R, Kelsh D, Kim MJ. Raofi S, et al. Clin Transl Sci. 2021 Sep;14(5):1977-1987. doi: 10.1111/cts.13053. Epub 2021 Jun 2. Clin Transl Sci. 2021. PMID: 33982418 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters